Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin. Read more about Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin.
Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness. Read more about Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness.
Design and synthesis of a PSMA inhibitor-doxorubicin conjugate for targeted prostate cancer therapy. Read more about Design and synthesis of a PSMA inhibitor-doxorubicin conjugate for targeted prostate cancer therapy.
2-5A ligands--a new concept for the treatment of prostate cancer. Read more about 2-5A ligands--a new concept for the treatment of prostate cancer.
Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats. Read more about Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats.
A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses. Read more about A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.
In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen. Read more about In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.
Structure-activity relationships of 2',5'-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists. Read more about Structure-activity relationships of 2',5'-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists.
Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: a feasibility study. Read more about Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: a feasibility study.
